Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Regular update of the Norwegian Laboratory Code System released

21 Jun 2022

In late May 2022, The Norwegian Directorate of e-Health released an updated version of the National Laboratory code (NLK) system (Norsk laboratoriekodeverk 7280.63)  to be implemented no later than July 01, 2022, and associated tariffs for state and private laboratories (Laboratoriekodeverk som gir rett til refusjon)  to be implemented no later than June 01, 2022.

NLK system is for activity-based reimbursement by the Norwegian Health Economics Administration (Helfo) in outpatient settings.

Seven new codes were added to NLK in the areas of immunology and transfusiology, clinical pharmacology, and medical microbiology. Furthermore, thirty-two codes implemented in March 2022 are now allocated to reimbursement tariffs.

See more information in Norwegian here (codes) and here (tariffs).

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).